184 related articles for article (PubMed ID: 29079437)
1. Investigation of molecular mechanism of recognition between citral and MARK4: A newer therapeutic approach to attenuate cancer cell progression.
Naz F; Khan FI; Mohammad T; Khan P; Manzoor S; Hasan GM; Lobb KA; Luqman S; Islam A; Ahmad F; Hassan MI
Int J Biol Macromol; 2018 Feb; 107(Pt B):2580-2589. PubMed ID: 29079437
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of human microtubule affinity-regulating kinase 4 inhibitors: fluorescence binding studies, enzyme, and cell assays.
Naz F; Sami N; Naqvi AT; Islam A; Ahmad F; Imtaiyaz Hassan M
J Biomol Struct Dyn; 2017 Nov; 35(14):3194-3203. PubMed ID: 27748164
[TBL] [Abstract][Full Text] [Related]
3. Designing New Kinase Inhibitor Derivatives as Therapeutics Against Common Complex Diseases: Structural Basis of Microtubule Affinity-Regulating Kinase 4 (MARK4) Inhibition.
Naz F; Shahbaaz M; Bisetty K; Islam A; Ahmad F; Hassan MI
OMICS; 2015 Nov; 19(11):700-11. PubMed ID: 26565604
[TBL] [Abstract][Full Text] [Related]
4. Structure-based investigation of MARK4 inhibitory potential of Naringenin for therapeutic management of cancer and neurodegenerative diseases.
Anwar S; Khan S; Shamsi A; Anjum F; Shafie A; Islam A; Ahmad F; Hassan MI
J Cell Biochem; 2021 Oct; 122(10):1445-1459. PubMed ID: 34121218
[TBL] [Abstract][Full Text] [Related]
5. Rosmarinic Acid Exhibits Anticancer Effects via MARK4 Inhibition.
Anwar S; Shamsi A; Shahbaaz M; Queen A; Khan P; Hasan GM; Islam A; Alajmi MF; Hussain A; Ahmad F; Hassan MI
Sci Rep; 2020 Jun; 10(1):10300. PubMed ID: 32587267
[TBL] [Abstract][Full Text] [Related]
6. PKR-inhibitor binds efficiently with human microtubule affinity-regulating kinase 4.
Naz F; Shahbaaz M; Khan S; Bisetty K; Islam A; Ahmad F; Hassan MI
J Mol Graph Model; 2015 Nov; 62():245-252. PubMed ID: 26519933
[TBL] [Abstract][Full Text] [Related]
7. Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4).
Mohammad T; Khan FI; Lobb KA; Islam A; Ahmad F; Hassan MI
J Biomol Struct Dyn; 2019 Apr; 37(7):1813-1829. PubMed ID: 29683402
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, molecular docking and inhibition studies of novel 3-N-aryl substituted-2-heteroarylchromones targeting microtubule affinity regulating kinase 4 inhibitors.
Parveen I; Khan P; Ali S; Hassan MI; Ahmed N
Eur J Med Chem; 2018 Nov; 159():166-177. PubMed ID: 30290280
[TBL] [Abstract][Full Text] [Related]
9. Identification of α-Mangostin as a Potential Inhibitor of Microtubule Affinity Regulating Kinase 4.
Khan P; Queen A; Mohammad T; Smita ; Khan NS; Hafeez ZB; Hassan MI; Ali S
J Nat Prod; 2019 Aug; 82(8):2252-2261. PubMed ID: 31343173
[TBL] [Abstract][Full Text] [Related]
10. Myricetin inhibits breast and lung cancer cells proliferation via inhibiting MARK4.
Anwar S; Khan S; Anjum F; Shamsi A; Khan P; Fatima H; Shafie A; Islam A; Hassan MI
J Cell Biochem; 2022 Feb; 123(2):359-374. PubMed ID: 34751461
[TBL] [Abstract][Full Text] [Related]
11. Elucidation of Dietary Polyphenolics as Potential Inhibitor of Microtubule Affinity Regulating Kinase 4: In silico and In vitro Studies.
Khan P; Rahman S; Queen A; Manzoor S; Naz F; Hasan GM; Luqman S; Kim J; Islam A; Ahmad F; Hassan MI
Sci Rep; 2017 Aug; 7(1):9470. PubMed ID: 28842631
[TBL] [Abstract][Full Text] [Related]
12. Structural and biochemical investigation of MARK4 inhibitory potential of cholic acid: Towards therapeutic implications in neurodegenerative diseases.
Anwar S; Shamsi A; Kar RK; Queen A; Islam A; Ahmad F; Hassan MI
Int J Biol Macromol; 2020 Oct; 161():596-604. PubMed ID: 32535203
[TBL] [Abstract][Full Text] [Related]
13. Probing the Inhibition of Microtubule Affinity Regulating Kinase 4 by N-Substituted Acridones.
Voura M; Khan P; Thysiadis S; Katsamakas S; Queen A; Hasan GM; Ali S; Sarli V; Hassan MI
Sci Rep; 2019 Feb; 9(1):1676. PubMed ID: 30737440
[TBL] [Abstract][Full Text] [Related]
14. Human microtubule affinity-regulating kinase 4 is stable at extremes of pH.
Naz F; Singh P; Islam A; Ahmad F; Imtaiyaz Hassan M
J Biomol Struct Dyn; 2016 Jun; 34(6):1241-51. PubMed ID: 26208600
[TBL] [Abstract][Full Text] [Related]
15. MAP/Microtubule Affinity Regulating Kinase 4 Inhibitory Potential of Irisin: A New Therapeutic Strategy to Combat Cancer and Alzheimer's Disease.
Waseem R; Anwar S; Khan S; Shamsi A; Hassan MI; Anjum F; Shafie A; Islam A; Yadav DK
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681645
[TBL] [Abstract][Full Text] [Related]
16. Targeting inhibition of microtubule affinity regulating kinase 4 by Harmaline: Strategy to combat Alzheimer's disease.
Adnan M; Anwar S; DasGupta D; Patel M; Elasbali AM; Alhassan HH; Shafie A; Siddiqui AJ; Bardakci F; Snoussi M; Hassan MI
Int J Biol Macromol; 2023 Jan; 224():188-195. PubMed ID: 36257368
[TBL] [Abstract][Full Text] [Related]
17. The structural analysis of MARK4 and the exploration of specific inhibitors for the MARK family: a computational approach to obstruct the role of MARK4 in prostate cancer progression.
Jenardhanan P; Mannu J; Mathur PP
Mol Biosyst; 2014 Jul; 10(7):1845-68. PubMed ID: 24763618
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin-associated domain of MARK4 provides stability at physiological pH.
Naz F; Sami N; Islam A; Ahmad F; Hassan MI
Int J Biol Macromol; 2016 Dec; 93(Pt A):1147-1154. PubMed ID: 27677563
[TBL] [Abstract][Full Text] [Related]
19. Design and development of Isatin-triazole hydrazones as potential inhibitors of microtubule affinity-regulating kinase 4 for the therapeutic management of cell proliferation and metastasis.
Aneja B; Khan NS; Khan P; Queen A; Hussain A; Rehman MT; Alajmi MF; El-Seedi HR; Ali S; Hassan MI; Abid M
Eur J Med Chem; 2019 Feb; 163():840-852. PubMed ID: 30579124
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of microtubule affinity regulating kinase 4 by an acetylcholinesterase inhibitor, Huperzine A: Computational and experimental approaches.
Alrouji M; DasGupta D; Ashraf GM; Bilgrami AL; Alhumaydhi FA; Al Abdulmonem W; Shahwan M; Alsayari A; Atiya A; Shamsi A
Int J Biol Macromol; 2023 Apr; 235():123831. PubMed ID: 36870649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
